Cost-effectiveness and quality-of-life assessment of GM-CSF as an adjunct to intensive remission induction chemotherapy in elderly patients with acute myeloid leukaemia-Reference-Cited by-同舟云学术

Cost-effectiveness and quality-of-life assessment of GM-CSF as an adjunct to intensive remission induction chemotherapy in elderly patients with acute myeloid leukaemia

Published:1998-03 Issue:4 Volume:100 Page:629-636
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:British Journal of Haematology

Author:

Uyl-DE Groot ,LÖwenberg ,Vellenga ,Suciu ,Willemze ,Rutten

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2141.1998.00635.x/fullpdf

Reference12 articles.

1. Measuring psychological and physical distress in cancer patients: structure and application of the Rotterdam Symptom Checklist;De Haes;British Journal of Cancer,1990

2. A controlled study of recombinant human granulocyte colony-stimulating factor in elderly patients after treatment for acute myelogenous leukemia;Dombret;New England Journal of Medicine,1995

3. Hunt , S.M. McEwen , J. McKenna , S.P. 1986 Measuring Health Status 241 245

4. Treatment of patients over 50 years of age with acute myelogenous leukemia with a combination of rubidazone and cytosine arabinoside, vincristine and prednisone (ROAP);Keating;Blood,1981

5. Mitoxantrone and cytosine arabinoside as first-line therapy in elderly patients with acute myeloid leukaemia;Liu Yin;British Journal of Haematology,1991

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A systematic review of health state utility values for older people with acute myeloid leukaemia;Quality of Life Research;2024-08-22

3. EQ-5D–Derived Health State Utility Values in Hematologic Malignancies: A Catalog of 796 Utilities Based on a Systematic Review;Value in Health;2020-07

4. Cost-effectiveness of midostaurin in the treatment of newly diagnosed FLT3-mutated acute myeloid leukemia in France;The European Journal of Health Economics;2020-01-22

5. Health state utilities associated with treatment options for acute myeloid leukemia (AML);Journal of Medical Economics;2019-03-29